­
­
­
­

Inventi Impact: Gastroenterology

Articles

  • Inventi:hgst/31233/20
    Safety and Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis in Patients with Inflammatory Bowel Disease in Special Situations: A Multicentre Cohort Study
    Research 2020 : April - June
    Satoshi Motoya, Hiroki Tanaka, Tomoyoshi Shibuya, Taro Osada, Takayuki Yamamoto, Hitoshi Hongo, Chiemi Mizuno, Daisuke Saito, Nobuo Aoyama, Toshihisa Kobayashi, Hiroaki Ito, Satoshi Tanida, Masanori Nojima, Seiichiro Kokuma, Eiji Hosoi

    Background: The available information on granulocyte and monocyte adsorptive apheresis (GMA) in patients\nwith inflammatory bowel disease (IBD) under special situations remains unclear. We conducted a retrospective,\nmulticentre cohort study to evaluate the safety and effectiveness of GMA in patients with IBD under special\nsituations.\nMethods: This study included patients with ulcerative colitis (UC) or Crohnâ??s disease who had at least one special\nsituation feature and who had received GMA between November 2013 and March 2017. The incidence of adverse\nevents (AEs) was compared in relation to the special situation, and patient background factors related to an AE\nwere identified..................

    How to Cite this Article
    Attribution/ CC Compliant Citation: Motoya, Satoshi, et al. \"Safety and effectiveness of granulocyte and monocyte adsorptive\napheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study.\" BMC gastroenterology\n19.1 (2019): 196.\nhttps://doi.org/10.1186/s12876-019-1110-1\nhttp://creativecommons.org/licenses/by/4.0/\n\nSome formatting elements, header, footer, logos, dates and pagination were modified while adapting this article.\n
    Download Full Text